Novavax, Inc. - Common Stock (NVAX)
8.6200
+0.1800 (2.13%)
Novavax Inc is a biotechnology company focused on the development and commercialization of innovative vaccines to prevent infectious diseases
The company harnesses its proprietary nanoparticle technology and adjuvant platforms to create safe and effective immunizations. Novavax aims to address public health challenges by producing vaccines for various diseases, prominently including those caused by emerging viral pathogens. Through its research and clinical trials, Novavax is committed to enhancing global health outcomes and responding efficiently to viral outbreaks.
Frequently Asked Questions
Is Novavax, Inc. - Common Stock publicly traded?
Yes, Novavax, Inc. - Common Stock is publicly traded.
What exchange does Novavax, Inc. - Common Stock trade on?
Novavax, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Novavax, Inc. - Common Stock?
The ticker symbol for Novavax, Inc. - Common Stock is NVAX on the Nasdaq Stock Market
What is the current price of Novavax, Inc. - Common Stock?
The current price of Novavax, Inc. - Common Stock is 8.620
When was Novavax, Inc. - Common Stock last traded?
The last trade of Novavax, Inc. - Common Stock was at 2:42 pm EST on February 5th, 2025
What is the market capitalization of Novavax, Inc. - Common Stock?
The market capitalization of Novavax, Inc. - Common Stock is 642.05M
How many shares of Novavax, Inc. - Common Stock are outstanding?
Novavax, Inc. - Common Stock has 74.48M shares outstanding.